Cingulate (CINGW) Invested Capital (2022 - 2026)
Cingulate's (CINGW) quarterly Invested Capital came in at $28.5 million in Q2 2026, up 186.59% quarter-over-quarter from $10.0 million in Q4 2025.
Analysis
Cingulate (CINGW) Invested Capital (2022 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Invested Capital for 5 consecutive years, with $28.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Invested Capital changed N/A year-over-year to $28.5 million; the trailing twelve-month figure through Jun 2026 stood at $28.5 million (changed N/A YoY), and the FY2025 full-year result was $10.0 million, down 95.94% from the prior year.
- Invested Capital improved to $28.5 million in Q2 2026 per CINGW's latest filing, from $10.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $28.5 million in Q2 2026 and bottomed at -$1.8 million in Q4 2023.
- Historically, Invested Capital has averaged $9.2 million across 5 years, with a median of $8.9 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Invested Capital slumped 119.92% in 2023, then soared 801.89% in 2024.
- Over 5 years, Invested Capital stood at $8.9 million in 2022, then plunged by 119.92% to -$1.8 million in 2023, then jumped by 801.89% to $12.4 million in 2024, then fell by 19.83% to $10.0 million in 2025, then jumped by 186.59% to $28.5 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $28.5 million, $10.0 million, and $6.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.24 Bn | 625.48 Bn | 17.26 Bn | 145.70 Bn |
| 2 | AbbVie | 441.52 Bn | 434.96 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 365.75 Bn | 358.60 Bn | 12.21 Bn | 159.97 Bn |
| 4 | Novartis Ag | 266.61 Bn | 258.92 Bn | 11.24 Bn | 51.53 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn | 148.69 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 106.05 Bn |
| 7 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 6.38 Bn |
| 9 | United Therapeutics | 21.43 Bn | 18.77 Bn | 683.80 Mn | - |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 28.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.53 Mn |
| Dec 31, 2025 | 9.96 Mn |
| Sep 30, 2025 | 6.66 Mn |
| Mar 31, 2025 | 10.98 Mn |
| Dec 31, 2024 | 12.42 Mn |
| Dec 31, 2023 | -1.77 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 5.08 Mn |
| Dec 31, 2022 | 8.88 Mn |
| Sep 30, 2022 | 13.37 Mn |